Fulgur Vitae

Fulgur Vitae is a biotechnology company focused on the development of therapies to reverse aging and treat mitochondrial-related diseases. The company's core technology is based on the research of founder Dr. Keshav Singh, which demonstrates that restoring mitochondrial function can reverse visible signs of aging such as skin wrinkles and hair loss. Fulgur Vitae utilizes a platform designed to repair mitochondrial DNA (mtDNA) and enhance mitochondrial oxidative phosphorylation. Their pipeline includes programs targeting dermatological aging and systemic mitochondrial dysfunction. The company aims to translate breakthrough genetic research into clinical applications for longevity and metabolic health. By targeting the root causes of cellular aging, Fulgur Vitae seeks to improve the healthspan of the aging population.